Bart Collet

The Q1 2026 Longevity Events Intelligence Report is live. 349 events. 3,100+ speakers. 6 analyses. New this quarter: Europe vs US Regional Analysis. Three findings: 1️⃣ EU peaks June + October (academic-led); US spreads year-round (C-suite-heavy) 2️⃣ 70 speakers active on both sides of the Atlantic 3️⃣ 66 events this quarter; North America 56%, Europe 23%, Asia 12% longevents.hyperadvancer.com/reports

Brief summary of several of the patient-facing AI health chatbots jmir.org/2026/1/e99230

Runtime 🤗🤩 #running

"YOUR CLAUDE CODE SESSION LIMIT HAS BEEN REACHED"

Once the participants are AI agents, the bottleneck flips. Idea generation becomes free; the scarce skill is designing the question, the jury criteria, and the ethical guardrails. The valuable work moves up a layer.

Here's the breakdown: hyperadvancer.com/blog/1000x-hac…

A hackathon with 1,000 human participants runs for 48 hours. A hackathon with 1,000 AI agents runs indefinitely, evaluates millions of ideas, and never hits a coffee wall. The format exists. The question is whether companies are ready to design for it.

During a discussion on top 80-ies food, someone mentioned “toast Hawaï” and I cannot top that.

AI-discovered compounds are clearing Phase I at 80 to 90%. Historical baseline: 40 to 65%. The bottleneck is no longer discovery; it's whether clinical practice can absorb what's coming.

Full Q1 breakdown: longevents.hyperadvancer.com/blog/what-happ…

$3.74B into longevity biotech in Q1 2026. 173 AI-discovered drugs in human trials. First FDA-approved mitochondrial therapy. The bottleneck is no longer discovery. It's delivery. That changes everything about where the opportunity actually is.

The formula separates two questions: 'is this a good idea?' (confidence × predicted value × time sensitivity) and 'is this a good idea for us?' (strategic fit). That split matters; most portfolio reviews conflate the two and fund familiar ideas rather than valuable ones.

Most innovation budgets die between 'this feels promising' and 'here's what it's worth.' The xV formula closes that gap; multiplying confidence, value, time sensitivity, and strategic fit into one weekly monetary figure. Does that cadence build discipline, or just bureaucracy?

BCG's full piece: is.gd/m9jNqy

The structural point that lands hardest: agentic networks are meant to determine *how* objectives get achieved, not just execute tasks. That moves strategy-setting to humans and execution to agents. Most governance frameworks aren't built for that split yet.

Most companies bolt AI onto org structures built for humans. This article argues that's the wrong order: redesign the organisation first, then let agents fill the roles. That inversion is harder than it sounds. Who owns the redesign when no one's title is 'org architect'?

Full breakdown: roulette.hyperadvancer.com/blog/5-unexpec…

The partnerships that seem absurd on paper are usually the ones worth watching. Nike + Apple. BMW + Louis Vuitton. Disney + NASA. In each case, the logic only becomes obvious in hindsight. What made them work when every instinct said they shouldn't?

60% of UK workers value private health insurance over an extra week of holiday. The C-suite already buys its own parallel longevity stack. Can HR rebuild around healthspan before the talent worth keeping notices the gap? linkedin.com/pulse/you-cant…

Oura sells $99 blood panels via Quest. WHOOP and Hims too. Function Health, valued at $2.5B, now integrates with ChatGPT Health for AI-assisted result interpretation. Patients are ordering tests their PCP never ordered, getting results their doctor never saw, and interpreting them with an AI their doctor doesn't control. Three migrations (diagnosis, monitoring, and interpretation) converging in a single consumer workflow. buff.ly/xkIc3eh #DrYou #FiveMigrations

Omdat #1mei elk jaar leidt tot Trumpiaans fake news: de 10% hoogste inkomens betalen 46% van alle personenbelasting. De hoogste helft betaalt 93%. De rest dus bijna niks. Wie solidariteit belangrijk vindt ontkent best niet het bestaan ervan, uit respect voor wie het feest betaalt